Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hempceuticals is a wellness and life sciences company that specializes in the production of hemp-derived cannabinoid products. The company focuses on utilizing cannabidiol (CBD) and other non-psychoactive compounds to address various health concerns, including chronic pain and inflammation. Their product line typically includes tinctures, capsules, and topical creams marketed as high-purity, pharmaceutical-grade supplements. Although positioned within the nutraceutical industry, the company emphasizes scientific extraction methods to ensure consistent cannabinoid profiles. Hempceuticals has historically targeted the growing consumer demand for natural alternatives to traditional analgesics and anxiolytics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hempcuticals.